Adlai Nortye Group Ltd.
ANL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944552
In the last 90 days, Adlai Nortye Group Ltd. insiders filed 0 open-market purchases and 2 sales; 42 institutions reported holding it in 13F filings for Q2 2026, worth $304.3M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $247.8K in total
- 2
- 13F holdersQ2 2026, +16 vs. previous quarter
- 42
- 13F valueReported value at the end of Q2 2026
- $304.3M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ANL, Q2 2026
No superinvestor reported holding ANL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Adlai Nortye Group Ltd. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 (view filing)11:07 AM ET | Sep 22 | 2 days | Ji PingDirector | SSaleAmerican Depository shares | −5.00K | $16.63 | −$83.2K | −3.7%131.7K after | |
| Aug 26, 2026 (view filing)4:28 PM ET | Aug 24-26 | 2 days | Ye XiaofengCFO | SSaleAmerican Depositary Shares | −11.7K | $14.11 | −$164.6K | −7.3%147.8K after | 2 lots |
| May 21, 2026 (view filing) | May 13 | 8 daysLate | Lu YangCEO | SSaleAmerican Depositary Shares | −10 | $13.18 | −$131.8 | 0.0%100.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Adlai Nortye Group Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 3,978,229 | $45.7M | 2.34% | +1,080,372+37.3% | Added |
| VR Adviser, LLC | 3,212,731 | $36.9M | 1.12% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 3,061,668 | $35.2M | 0.06% | +2,183,822+248.8% | Added |
| Point72 Asset Management, L.P. | 2,140,664 | $24.6M | 0.04% | +2,140,664 | New |
| MPM Oncology Impact Management LP | 1,936,291 | $22.3M | 1.36% | +1,936,291 | New |
| Perceptive Advisors LLC | 1,793,190 | $20.6M | 0.32% | +1,793,190 | New |
| Casdin Capital, LLC | 1,250,000 | $14.4M | 0.72% | +711,539+132.1% | Added |
| ADAR1 Capital Management, LLC | 1,017,805 | $11.7M | 0.55% | +899,896+763.2% | Added |
| Octagon Capital Advisors LP | 934,716 | $10.7M | 0.99% | +934,716 | New |
| Millennium Management LLC | 807,832 | $9.29M | 0.01% | +126,057+18.5% | Added |